Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Inhibition of microRNA function by antimiR oligonucleotides.
Stenvang J, Petri A, Lindow M, Obad S, Kauppinen S.
Silence. 2012 Jan 9;3(1):1.
Related citations
LNA-mediated microRNA silencing in non-human primates.
Elmén J, Lindow M, Schütz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjärn M, Hansen HF, Berger U, Gullans S, Kearney P, Sarnow P, Straarup EM, Kauppinen S.
Nature. 2008 Apr 17;452(7189):896-9. Epub 2008 Mar 26.
Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease.
Kaucsár T, Rácz Z, Hamar P.
Adv Drug Deliv Rev. 2010 Nov 30;62(14):1390-401. Epub 2010 Oct 19. Review.
MicroRNAs in cancer management and their modulation by dietary agents.
Karius T, Schnekenburger M, Dicato M, Diederich M.
Biochem Pharmacol. 2012 Jun 15;83(12):1591-601. Epub 2012 Feb 9.
MicroRNAs as targets for antisense-based therapeutics.
Stenvang J, Kauppinen S.
Expert Opin Biol Ther. 2008 Jan;8(1):59-81. Review.
MicroRNAs and their diverse functions in plants.
Sun G.
Plant Mol Biol. 2011 Aug 27. [Epub ahead of print]
Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?
Weiler J, Hunziker J, Hall J.
Gene Ther. 2006 Mar;13(6):496-502. Review.
Inter- and intra-combinatorial regulation by transcription factors and microRNAs.
Zhou Y, Ferguson J, Chang JT, Kluger Y.
BMC Genomics. 2007 Oct 30;8:396.
Exploiting the therapeutic potential of microRNAs in viral diseases: expectations and limitations.
Hemida MG, Ye X, Thair S, Yang D.
Mol Diagn Ther. 2010 Oct 1;14(5):271-82. doi: 10.2165/11539540-000000000-00000. Review.
Toward microRNA-based therapeutics for heart disease: the sense in antisense.
van Rooij E, Marshall WS, Olson EN.
Circ Res. 2008 Oct 24;103(9):919-28. Review.
microRNA target predictions in animals.
Rajewsky N.
Nat Genet. 2006 Jun;38 Suppl:S8-13. Review.
Strategies to identify microRNA targets: new advances.
Jin H, Tuo W, Lian H, Liu Q, Zhu XQ, Gao H.
N Biotechnol. 2010 Dec 31;27(6):734-8. Epub 2010 Oct 1. Review.
MicroRNAs: novel regulators in cardiac development and disease.
Thum T, Catalucci D, Bauersachs J.
Cardiovasc Res. 2008 Sep 1;79(4):562-70. Epub 2008 May 29. Review.
Targeting of microRNAs for therapeutics.
Stenvang J, Lindow M, Kauppinen S.
Biochem Soc Trans. 2008 Dec;36(Pt 6):1197-200.
LNA-modified oligonucleotides mediate specific inhibition of microRNA function.
Ørom UA, Kauppinen S, Lund AH.
Gene. 2006 May 10;372:137-41. Epub 2006 Feb 24.
MicroRNA silencing in primates: towards development of novel therapeutics.
Petri A, Lindow M, Kauppinen S.
Cancer Res. 2009 Jan 15;69(2):393-5. Review.
MicroRNA therapeutics: a new niche for antisense nucleic acids.
Hammond SM.
Trends Mol Med. 2006 Mar;12(3):99-101. Epub 2006 Feb 10.
The utility of LNA in microRNA-based cancer diagnostics and therapeutics.
Stenvang J, Silahtaroglu AN, Lindow M, Elmen J, Kauppinen S.
Semin Cancer Biol. 2008 Apr;18(2):89-102. Epub 2008 Jan 15. Review.
Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4.
Xiao J, Yang B, Lin H, Lu Y, Luo X, Wang Z.
J Cell Physiol. 2007 Aug;212(2):285-92. Retraction in: J Cell Physiol. 2012 Feb;227(2):877.
MicroRNAs in leukemias: emerging diagnostic tools and therapeutic targets.
Mian YA, Zeleznik-Le NJ.
Curr Drug Targets. 2010 Jul;11(7):801-11. Review.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on